An Escalating Dose Tolerance Trial of BG8962 (rCD4) in Patients Who Are HIV Antibody Positive
Clinical trial NCT00000721 · COMPLETED
Trial details
- NCT number
- NCT00000721
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.